Northwest Biotherapeutics Stock Price Prediction
| NWBO Stock | USD 0.29 0.01 3.33% |
Oversold Vs Overbought
45
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Northwest Biotherapeutics based on different types of headlines from major news networks to social media. Using Northwest Biotherapeutics hype-based prediction, you can estimate the value of Northwest Biotherapeutics from the perspective of Northwest Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Northwest Biotherapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Northwest Biotherapeutics to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Northwest because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Northwest Biotherapeutics after-hype prediction price | USD 0.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Northwest |
Northwest Biotherapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Northwest Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Northwest Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Northwest Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Northwest Biotherapeutics Estimiated After-Hype Price Volatility
In the context of predicting Northwest Biotherapeutics' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Northwest Biotherapeutics' historical news coverage. Northwest Biotherapeutics' after-hype downside and upside margins for the prediction period are 0.01 and 4.27, respectively. We have considered Northwest Biotherapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Northwest Biotherapeutics is out of control at this time. Analysis and calculation of next after-hype price of Northwest Biotherapeutics is based on 3 months time horizon.
Northwest Biotherapeutics OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Northwest Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Northwest Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Northwest Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.03 | 3.95 | 0.00 | 0.01 | 0 Events / Month | 8 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.29 | 0.29 | 0.00 |
|
Northwest Biotherapeutics Hype Timeline
Northwest Biotherapeutics is now traded for 0.29. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Northwest is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.03%. %. The volatility of related hype on Northwest Biotherapeutics is about 1366.78%, with the expected price after the next announcement by competition of 0.28. The company recorded a loss per share of 0.06. Northwest Biotherapeutics had not issued any dividends in recent years. The entity had 1:16 split on the 26th of September 2012. Given the investment horizon of 90 days the next forecasted press release will be uncertain. Check out Northwest Biotherapeutics Basic Forecasting Models to cross-verify your projections.Northwest Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Northwest Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Northwest Biotherapeutics' future price movements. Getting to know how Northwest Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Northwest Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EQ | Equillium | (0.25) | 8 per month | 0.00 | (0.02) | 13.33 | (8.24) | 64.12 | |
| DMAC | DiaMedica Therapeutics | (0.07) | 6 per month | 2.34 | 0.09 | 6.41 | (3.85) | 18.09 | |
| VALN | Valneva SE ADR | (0.06) | 3 per month | 0.00 | (0.33) | 3.60 | (6.16) | 11.78 | |
| VANI | Vivani Medical | 0.00 | 9 per month | 2.56 | 0.01 | 5.11 | (4.24) | 20.23 | |
| DNLI | Denali Therapeutics | (1.18) | 9 per month | 0.00 | (0.09) | 6.73 | (5.35) | 22.00 | |
| DNTH | Dianthus Therapeutics | 0.25 | 7 per month | 0.00 | (0.07) | 7.13 | (6.74) | 16.65 | |
| DOMH | Dominari Holdings | 0.11 | 4 per month | 0.00 | (0.10) | 6.41 | (4.69) | 23.01 | |
| VCEL | Vericel Corp Ord | (2.89) | 9 per month | 2.03 | 0.12 | 5.15 | (3.52) | 12.86 | |
| VCNX | Vaccinex | 0.08 | 6 per month | 0.00 | (0.03) | 11.52 | (16.55) | 54.95 | |
| VCYT | Veracyte | 1.12 | 10 per month | 2.12 | 0.17 | 5.42 | (3.60) | 14.52 |
Northwest Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Northwest price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Northwest using various technical indicators. When you analyze Northwest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Northwest Biotherapeutics Predictive Indicators
The successful prediction of Northwest Biotherapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Northwest Biotherapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Northwest Biotherapeutics based on analysis of Northwest Biotherapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Northwest Biotherapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Northwest Biotherapeutics's related companies.
Story Coverage note for Northwest Biotherapeutics
The number of cover stories for Northwest Biotherapeutics depends on current market conditions and Northwest Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Northwest Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Northwest Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Northwest Biotherapeutics Short Properties
Northwest Biotherapeutics' future price predictability will typically decrease when Northwest Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Northwest Biotherapeutics often depends not only on the future outlook of the potential Northwest Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Northwest Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 948.4 M | |
| Cash And Short Term Investments | 15.2 M |
Other Information on Investing in Northwest OTC Stock
Northwest Biotherapeutics financial ratios help investors to determine whether Northwest OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Northwest with respect to the benefits of owning Northwest Biotherapeutics security.